Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
Clinical trial NCT00412542 · COMPLETED
Trial details
- NCT number
- NCT00412542
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2009-10-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.